Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 147.56
+1.06 (0.72%)
Sep 4, 2026, 4:08 PM GMT
Diaceutics Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 124 | 109 | 106 | 73 | 64 | 86 | |
Market Cap Growth | 4.96% | 2.47% | 44.66% | 15.14% | -25.74% | -23.60% |
Enterprise Value | 118 | 99 | 90 | 57 | 45 | 62 |
Last Close Price | 1.47 | 1.28 | 1.25 | 0.87 | 0.76 | 1.02 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 1281.96 | 1120.49 | - | - | 87.95 | 152.85 |
Forward PE | 176.51 | 49.23 | 24.77 | 24.77 | 30.32 | 40.80 |
PS Ratio | 3.24 | 2.83 | 3.30 | 3.09 | 3.27 | 6.15 |
PB Ratio | 3.07 | 2.69 | 2.66 | 1.80 | 1.50 | 2.11 |
P/TBV Ratio | 5.10 | 4.45 | 4.34 | 2.87 | 2.32 | 3.06 |
P/FCF Ratio | 112.23 | 98.09 | 192.50 | 61.82 | 12.97 | 17150.06 |
P/OCF Ratio | 105.47 | 92.19 | 162.93 | 55.93 | 12.50 | 150.44 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.07 | 2.59 | 2.81 | 2.39 | 2.29 | 4.46 |
EV/EBITDA Ratio | 27.00 | 24.34 | 163.86 | 555.87 | 21.53 | 40.96 |
EV/EBIT Ratio | - | 2312.51 | - | - | 77.74 | 112.96 |
EV/FCF Ratio | 106.64 | 89.75 | 164.16 | 47.81 | 9.10 | 12425.86 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
Debt / EBITDA Ratio | 0.26 | 0.26 | 1.50 | 4.73 | 0.60 | 1.00 |
Debt / FCF Ratio | 1.04 | 1.04 | 1.92 | 1.02 | 0.27 | 312.20 |
Net Debt / Equity Ratio | -0.15 | -0.15 | -0.29 | -0.38 | -0.43 | -0.45 |
Net Debt / EBITDA Ratio | -1.52 | -1.52 | -21.17 | -151.59 | -8.92 | -11.94 |
Net Debt / FCF Ratio | -5.59 | -5.59 | -21.20 | -13.04 | -3.77 | -3622.80 |
Asset Turnover | 0.78 | 0.78 | 0.68 | 0.50 | 0.42 | 0.32 |
Quick Ratio | 3.30 | 3.30 | 3.66 | 6.11 | 8.07 | 11.24 |
Current Ratio | 3.43 | 3.43 | 3.80 | 6.40 | 8.24 | 11.41 |
Return on Equity (ROE) | 0.24% | 0.24% | -4.22% | -4.19% | 1.74% | 1.39% |
Return on Assets (ROA) | 0.05% | 0.05% | -3.23% | -3.99% | 0.77% | 0.78% |
Return on Invested Capital (ROIC) | 0.04% | 0.04% | -9.18% | -12.24% | 2.47% | 2.92% |
Return on Capital Employed (ROCE) | 0.10% | 0.10% | -6.00% | -7.20% | 1.30% | 1.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.08% | 0.09% | -1.61% | -2.38% | 1.14% | 0.65% |
FCF Yield | 0.89% | 1.02% | 0.52% | 1.62% | 7.71% | 0.01% |
Buyback Yield / Dilution | -0.80% | -0.80% | -0.27% | 2.16% | -1.35% | -9.14% |